Suppliers / Shandong Cheminspire Pharmaceutical

Shandong Cheminspire Pharmaceutical

China Updated 9 July 2026

Shandong Cheminspire Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

Questions about Shandong Cheminspire Pharmaceutical

Does Shandong Cheminspire Pharmaceutical hold a US DMF or a CEP?
Shandong Cheminspire Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Shandong Cheminspire Pharmaceutical make?
2 molecules are on record against Shandong Cheminspire Pharmaceutical, including Lenacapavir and Resmetirom. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shandong Cheminspire Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability